Research programme: platinum derivativesAlternative Names: Platinum derivatives - research programme Andrulis; Platinum derivatives SAP, poly-plat, SSP
Latest Information Update: 20 Sep 2006
At a glance
- Originator Andrulis Pharmaceuticals
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 20 Sep 2006 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 24 Mar 1999 New profile
- 05 Mar 1999 Preclinical development for Cancer in USA (Unknown route)